Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 129 publications
Effects of Evolocumab on Mortality Outcomes in Patients Without Previous Myocardial Infarction or Stroke: A Prespecified Analysis of the VESALIUS-CV Randomized Clinical Trial.
Journal: Circulation
Published: August 31, 2026
Vasoactive Agent Selection Strategies in the Management of Cardiogenic Shock.
Journal: Circulation
Published: August 24, 2026
Cumulative Benefit With Evolocumab in Patients With No Prior Myocardial Infarction or Stroke in the VESALIUS-CV Study.
Journal: Journal of the American College of Cardiology
Published: July 07, 2026
Evolocumab and risk of first myocardial infarction: the VESALIUS-CV trial.
Journal: European heart journal
Published: July 07, 2026
Beyond Siloed Care: The Promise and Challenge of Cardiovascular-Kidney-Metabolic Syndrome.
Journal: Circulation
Published: June 09, 2026
Cardiac Intensive Care Unit Appropriate Patient Selection and Triage: A Scientific Statement From the American Heart Association.
Journal: Circulation
Published: May 21, 2026
Evolocumab in Patients With Prior Percutaneous Coronary Intervention and No Prior Myocardial Infarction: Results From the VESALIUS-CV Trial.
Journal: Circulation
Published: May 19, 2026
Variation in Vasoactive Treatment Selection for Cardiogenic Shock: Insights From the Critical Care Cardiology Trials Network (CCCTN).
Journal: Circulation. Heart failure
Published: May 07, 2026
Evolocumab in Patients With High-Risk Diabetes: Results From the VESALIUS-CV Trial.
Journal: Diabetes care
Published: April 13, 2026
Last Updated: 09/26/2026